NFKB1 and neoplasm: In particular, a BRCA1-deficient, NF-κB-driven immune signal (“NF-κB on”) was identified concomitant with a favorable “M1-type” macrophage tumor microenvironment, promoting active cytotoxic CD8+ infiltration.